LGND logo

LGND Retained earnings

annual retained earnings:

$498.98M-$4.03M(-0.80%)
December 31, 2024

Summary

  • As of today (June 1, 2025), LGND annual retained earnings is $498.98 million, with the most recent change of -$4.03 million (-0.80%) on December 31, 2024.
  • During the last 3 years, LGND annual retained earnings has risen by +$49.89 million (+11.11%).
  • LGND annual retained earnings is now -0.80% below its all-time high of $503.02 million, reached on December 31, 2023.

Performance

LGND Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

quarterly retained earnings:

$456.53M-$42.45M(-8.51%)
March 31, 2025

Summary

  • As of today (June 1, 2025), LGND quarterly retained earnings is $456.53 million, with the most recent change of -$42.45 million (-8.51%) on March 31, 2025.
  • Over the past year, LGND quarterly retained earnings has dropped by -$132.62 million (-22.51%).
  • LGND quarterly retained earnings is now -22.51% below its all-time high of $589.15 million, reached on March 31, 2024.

Performance

LGND quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

LGND Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.8%-22.5%
3 y3 years+11.1%-2.6%
5 y5 years+24.7%+23.1%

LGND Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.8%+11.1%-22.5%+1.3%
5 y5-year-0.8%+27.3%-22.5%+23.1%
alltimeall time-0.8%+157.8%-22.5%+145.5%

LGND Retained earnings History

DateAnnualQuarterly
Mar 2025
-
$456.53M(-8.5%)
Dec 2024
$498.98M(-0.8%)
$498.98M(-5.9%)
Sep 2024
-
$530.07M(-1.3%)
Jun 2024
-
$537.24M(-8.8%)
Mar 2024
-
$589.15M(+17.1%)
Dec 2023
$503.02M(+11.6%)
$503.02M(+3.8%)
Sep 2023
-
$484.83M(-2.1%)
Jun 2023
-
$495.10M(+0.5%)
Mar 2023
-
$492.81M(+9.3%)
Dec 2022
$450.86M(+0.4%)
$450.86M(-3.7%)
Sep 2022
-
$468.35M(+0.1%)
Jun 2022
-
$467.94M(-0.2%)
Mar 2022
-
$468.84M(+4.4%)
Dec 2021
$449.09M(+14.6%)
$449.09M(-1.2%)
Sep 2021
-
$454.51M(+3.1%)
Jun 2021
-
$440.78M(+7.5%)
Mar 2021
-
$410.06M(+4.6%)
Dec 2020
$391.95M(-2.0%)
$391.95M(+1.5%)
Sep 2020
-
$386.19M(-1.7%)
Jun 2020
-
$392.89M(+6.0%)
Mar 2020
-
$370.81M(-7.3%)
Dec 2019
$400.11M(-274.6%)
$400.11M(-1.8%)
Sep 2019
-
$407.47M(-3.6%)
Jun 2019
-
$422.72M(-3.3%)
Mar 2019
-
$437.14M(-290.7%)
Dec 2018
-$229.20M(-42.8%)
-$229.20M(+24.6%)
Sep 2018
-
-$183.91M(-27.7%)
Jun 2018
-
-$254.24M(-22.3%)
Mar 2018
-
-$327.40M(-18.3%)
Dec 2017
-$400.92M(-7.0%)
-$400.92M(+1.8%)
Sep 2017
-
-$393.91M(-2.1%)
Jun 2017
-
-$402.34M(-1.5%)
Mar 2017
-
-$408.40M(-5.3%)
Dec 2016
-$431.13M(+0.4%)
-$431.13M(+0.7%)
Sep 2016
-
-$428.00M(+6.7%)
Jun 2016
-
-$401.17M(+1.5%)
Mar 2016
-
-$395.40M(-7.9%)
Dec 2015
-$429.49M(-34.9%)
-$429.49M(+4.6%)
Sep 2015
-
-$410.46M(-35.4%)
Jun 2015
-
-$635.00M(-3.6%)
Mar 2015
-
-$658.56M(-0.1%)
Dec 2014
-$659.32M(-1.8%)
-$659.32M(-1.1%)
Sep 2014
-
-$666.37M(-0.2%)
Jun 2014
-
-$667.65M(-0.2%)
Mar 2014
-
-$669.24M(-0.3%)
Dec 2013
-$671.34M(-1.7%)
-$671.34M(-0.3%)
Sep 2013
-
-$673.21M(-0.3%)
Jun 2013
-
-$675.17M(-0.9%)
Mar 2013
-
-$681.26M(-0.2%)
Dec 2012
-$682.76M(+0.1%)
-$682.76M(-0.2%)
Sep 2012
-
-$683.82M(+0.2%)
Jun 2012
-
-$682.65M(+0.3%)
Mar 2012
-
-$680.39M(-0.3%)
Dec 2011
-$682.23M(-1.4%)
-$682.23M(-0.7%)
Sep 2011
-
-$687.27M(+0.6%)
Jun 2011
-
-$683.38M(+0.1%)
Mar 2011
-
-$682.46M(-1.4%)
Dec 2010
-$691.95M(+1.5%)
-$691.95M(-0.6%)
Sep 2010
-
-$696.45M(+1.7%)
Jun 2010
-
-$684.61M(+0.0%)
Mar 2010
-
-$684.33M(+0.4%)
Dec 2009
-$681.57M
-$681.57M(-0.4%)
DateAnnualQuarterly
Sep 2009
-
-$684.58M(-0.3%)
Jun 2009
-
-$686.39M(+0.2%)
Mar 2009
-
-$684.72M(+0.7%)
Dec 2008
-$679.63M(+16.9%)
-$679.63M(+11.4%)
Sep 2008
-
-$610.00M(+3.1%)
Jun 2008
-
-$591.87M(+1.1%)
Mar 2008
-
-$585.45M(+0.7%)
Dec 2007
-$581.51M(-32.6%)
-$581.51M(-1.0%)
Sep 2007
-
-$587.45M(-0.2%)
Jun 2007
-
-$588.70M(-0.0%)
Mar 2007
-
-$588.88M(-31.7%)
Dec 2006
-$862.80M(+3.8%)
-$862.80M(-14.1%)
Sep 2006
-
-$1.00B(+1.5%)
Jun 2006
-
-$989.25M(+1.6%)
Mar 2006
-
-$973.29M(+17.1%)
Dec 2005
-$831.06M(+4.6%)
-$831.06M(+0.3%)
Sep 2005
-
-$828.34M(+0.8%)
Jun 2005
-
-$822.06M(+1.1%)
Mar 2005
-
-$813.13M(+2.3%)
Dec 2004
-$794.66M(+6.0%)
-$794.66M(+15.2%)
Sep 2004
-
-$689.92M(+1.0%)
Jun 2004
-
-$683.13M(+2.1%)
Mar 2004
-
-$668.92M(-10.8%)
Dec 2003
-$749.52M(+21.2%)
-$749.52M(+13.3%)
Sep 2003
-
-$661.72M(+1.7%)
Jun 2003
-
-$650.63M(+1.9%)
Mar 2003
-
-$638.64M(+3.3%)
Dec 2002
-$618.32M(+5.6%)
-$618.32M(+1.1%)
Sep 2002
-
-$611.59M(+1.2%)
Jun 2002
-
-$604.54M(+2.1%)
Mar 2002
-
-$592.29M(+1.1%)
Dec 2001
-$585.72M(+7.9%)
-$585.72M(+2.3%)
Sep 2001
-
-$572.66M(+1.4%)
Jun 2001
-
-$564.92M(+1.9%)
Mar 2001
-
-$554.31M(+2.1%)
Dec 2000
-$542.73M(+15.4%)
-$542.73M(+5.0%)
Sep 2000
-
-$516.69M(+3.0%)
Jun 2000
-
-$501.76M(+3.4%)
Mar 2000
-
-$485.30M(+3.2%)
Dec 1999
-$470.30M(+18.9%)
-$470.30M(+5.1%)
Sep 1999
-
-$447.50M(+4.3%)
Jun 1999
-
-$429.20M(+4.6%)
Mar 1999
-
-$410.20M(+3.7%)
Dec 1998
-$395.60M(+42.5%)
-$395.60M(+11.4%)
Sep 1998
-
-$355.00M(+15.0%)
Jun 1998
-
-$308.70M(+6.0%)
Mar 1998
-
-$291.30M(+4.9%)
Dec 1997
-$277.70M(+56.4%)
-$277.70M(+32.4%)
Sep 1997
-
-$209.70M(+5.9%)
Jun 1997
-
-$198.10M(+5.5%)
Mar 1997
-
-$187.70M(+5.7%)
Dec 1996
-$177.60M(+26.6%)
-$177.60M(+7.1%)
Sep 1996
-
-$165.80M(+5.3%)
Jun 1996
-
-$157.40M(+6.8%)
Mar 1996
-
-$147.40M(+5.1%)
Dec 1995
-$140.30M(+84.4%)
-$140.30M(+6.4%)
Sep 1995
-
-$131.90M(+61.1%)
Mar 1995
-
-$81.90M(+7.6%)
Dec 1994
-$76.10M
-$76.10M(+9.3%)
Sep 1994
-
-$69.60M(+10.0%)
Jun 1994
-
-$63.30M(+13.0%)
Mar 1994
-
-$56.00M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual retained earnings?
  • What is the all time high annual retained earnings for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual retained earnings year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual retained earnings?

The current annual retained earnings of LGND is $498.98M

What is the all time high annual retained earnings for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual retained earnings is $503.02M

What is Ligand Pharmaceuticals Incorporated annual retained earnings year-on-year change?

Over the past year, LGND annual retained earnings has changed by -$4.03M (-0.80%)

What is Ligand Pharmaceuticals Incorporated quarterly retained earnings?

The current quarterly retained earnings of LGND is $456.53M

What is the all time high quarterly retained earnings for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly retained earnings is $589.15M

What is Ligand Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?

Over the past year, LGND quarterly retained earnings has changed by -$132.62M (-22.51%)
On this page